Assay reproducibility and within-person variation of Müllerian inhibiting substance

Fertility and Sterility

Volumn 94, Issue 1, 2010, Pages 301-304

  Dorgan, Joanne F ^a   Spittle, Cynthia S ^b   Egleston, Brian L ^a   Shaw, Christiana M ^a   Kahle, Lisa L ^c   Brinton, Louise A ^d  

^a FOX CHASE CANCER CENTER   (United States)

^b PFIZER INC   (United States)

^c INFORMATION MANAGEMENT SERVICES INC   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

antimullerian hormone (AMH); assay reproducibility; coefficient of variation (CV); intraclass correlation coefficient (ICC); M llerian inhibiting substance (MIS); within person variation

Indexed keywords

MUELLERIAN INHIBITING FACTOR;

ADULT; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; MENSTRUAL CYCLE; OVARY FUNCTION; PREMENOPAUSE; PRIORITY JOURNAL; REPRODUCIBILITY; UNITED STATES;

ADULT; ANTI-MULLERIAN HORMONE; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; PILOT PROJECTS; REPRODUCIBILITY OF RESULTS;

EID: 77952545857     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.03.032     Document Type: Article

References (19)

1. Teixeira J., Maheswaran S., and Donahoe P.K. Müllerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications. Endocr Rev 22 (2001) 657-674
2. Lee M.M., Donahoe P.K., Hasegawa T., Silverman B., Crist G.B., Best S., et al. Müllerian inhibiting substance in humans: normal levels from infancy to adulthood. J Clin Endocrinol Metab 81 (1996) 571-576
3. de Vet A., Laven J.S., de Jong F.H., Themmen A.P., and Fauser B.C. Antimullerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril 77 (2002) 357-362
4. van Rooij I.A., Broekmans F.J., Scheffer G.J., Looman C.W., Habbema J.D., de Jong F.H., et al. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril 83 (2005) 979-987
5. Pigny P., Merlen E., Robert Y., Cortet-Rudelli C., Decanter C., Jonard S., et al. Elevated serum level of antimullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab 88 (2003) 5957-5962
6. Pastor C.L., Vanderhoof V.H., Lim L.C., Calis K.A., Premkumar A., Guerrero N.T., et al. Pilot study investigating the age-related decline in ovarian function of regularly menstruating normal women. Fertil Steril 84 (2005) 1462-1469
7. de Carvalho B.R., Rosa e Silva A.C., Rosa e Silva J.C., dos Reis R.M., Ferriani R.A., and Silva de Sa M.F. Ovarian reserve evaluation: state of the art. J Assist Reprod Genet 25 (2008) 311-322
8. Piltonen T., Morin-Papunen L., Koivunen R., Perheentupa A., Ruokonen A., and Tapanainen J.S. Serum antiMüllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Hum Reprod 20 (2005) 1820-1826
9. El-Halawaty S., Rizk A., Kamal M., Aboulhassan M., Al-Sawah H., Noah O., et al. Clinical significance of serum concentration of antiMüllerian hormone in obese women with polycystic ovary syndrome. Reprod Biomed Online 15 (2007) 495-499
10. La Marca A., and Volpe A. The anti-mullerian hormone and ovarian cancer. Hum Reprod Update 13 (2007) 265-273
11. Snedecor G.W., and Cochran W.G. Statistical methods. 7th ed. (1980), Iowa State University, Ames, IA
12. Fleiss J.L. The design and analysis of clinical experiments (1986), Wiley-Interscience, New York
13. Mulders A.G., Laven J.S., Eijkemans M.J., de Jong F.H., Themmen A.P., and Fauser B.C. Changes in antimullerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility. Hum Reprod 19 (2004) 2036-2042
14. Cook C.L., Siow Y., Taylor S., and Fallat M.E. Serum mullerian-inhibiting substance levels during normal menstrual cycles. Fertil Steril 73 (2000) 859-861
15. Hehenkamp W.J., Looman C.W., Themmen A.P., de Jong F.H., Te Velde E.R., and Broekmans F.J. Anti-mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. J Clin Endocrinol Metab 91 (2006) 4057-4063
16. Laven J.S., Mulders A.G., Visser J.A., Themmen A.P., De Jong F.H., and Fauser B.C. Anti-mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab 89 (2004) 318-323
17. England TE, Delarey C, Strauss J, Freeman EW. Analytical performance characteristics of a quantitative ELISA for anti-mullerian hormone (AMH): an endocrine marker of ovarian aging. American Association for Clinical Chemistry Annual Meeting, 2005. www.clinchem.org/misc/meetingabstracts.shtml.
18. Fanchin R., Taieb J., Lozano D.H., Ducot B., Frydman R., and Bouyer J. High reproducibility of serum antimullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status. Hum Reprod 20 (2005) 923-927
19. La Marca A., Stabile G., Artenisio A.C., and Volpe A. Serum antimullerian hormone throughout the human menstrual cycle. Hum Reprod 21 (2006) 3103-3107